Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human ex vivo in vitro model

Clinical Pharmacology and Therapeutics
U KlinkhardtS Harder

Abstract

Formation of platelet-leukocyte aggregates (PLA) through the CD62 ligand is an important mechanism by which leukocytes contribute to thrombosis and inflammation. We investigated the formation of PLA in human subjects after stimulation with thrombin receptor activating peptide and adenosine diphosphate (ADP) after treatment with clopidogrel and after in vitro application of the platelet glycoprotein IIb/IIIa complex antagonist abciximab. Expression of CD62 was significantly reduced 30% to 50% with clopidogrel, depending on the type and concentration of the inducer, but addition of abciximab led to a significant approximately 30% increase in CD62 expression when platelets were stimulated by ADP. Formation of PLA decreased significantly with clopidogrel to 55% to 75% of the baseline value, whereas addition of abciximab caused a significant increase in PLA in ADP-stimulated samples before but not after administration of clopidogrel. The increase in formation of PLA after in vitro addition of abciximab was not paralleled by a decrease in platelet microaggregates and is therefore presumed not caused by enhanced availability of platelets. To our knowledge, this is the first report showing that clopidogrel reduces formation of PLA. The...Continue Reading

Citations

Nov 30, 2007·Journal of the American Society of Nephrology : JASN·Xiaowen TuJianjun Li
Sep 7, 2007·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Farrah J Mateen, Ashfaq Shuaib
Aug 15, 2009·Expert Opinion on Investigational Drugs·Italo PortoFilippo Crea
May 25, 2004·Expert Opinion on Investigational Drugs·Jean-Marc Herbert
May 7, 2015·Proceedings of the National Academy of Sciences of the United States of America·Vasudharani DevanathanBernd Nürnberg
Aug 1, 2015·Thrombosis and Haemostasis·Karin A L MüllerTobias Geisler
Jul 20, 2004·British Journal of Haematology·Patrick André
Jul 14, 2006·Journal of Thrombosis and Haemostasis : JTH·G Davì, F Santilli
Jun 7, 2005·Expert Opinion on Pharmacotherapy·Hans-Christoph DienerPierre Savi
Aug 26, 2014·Frontiers in Physiology·Philipp von Hundelshausen, Martin M N Schmitt
Mar 3, 2011·Chest·Jason N KatzRichard C Becker
Nov 17, 2010·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Anastazia A KeiEvangelos N Liberopoulos
Jan 2, 2003·Nature Reviews. Drug Discovery·Deepak L Bhatt, Eric J Topol
May 17, 2013·Journal of the American Heart Association·Michelle A Berny-LangAndrew L Frelinger
Aug 23, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Catherine LeonChristian Gachet
Jul 3, 2007·British Journal of Pharmacology·S C Pitchford
Jul 26, 2005·British Journal of Pharmacology·Laura MoleroCarlos Macaya
Sep 24, 2005·European Heart Journal·Joerg Herrmann
Oct 1, 2005·Platelets·W Lösche
May 5, 2011·British Journal of Haematology·John D WelshCarla V Finkielstein
Mar 1, 2005·European Heart Journal·Albert SchömigUNKNOWN Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Study Investigators
Nov 30, 2004·Zeitschrift für Kardiologie·M Merten, P Thiagarajan
Sep 16, 2010·Cardiovascular Therapeutics·Rémy ChenevardFrank Ruschitzka
Oct 19, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Abduelhakem Ben AddiBernard Robaye
Jun 24, 2003·The American Journal of Cardiology·Andrew P Selwyn
Sep 4, 2007·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Yunus AyralKlaus Pels
Jul 9, 2008·Journal of Molecular and Cellular Cardiology·Peter D O'KaneAlbert Ferro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Therapeutics
Mukesh SinghRohit Arora
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Saihari Sadanandan, Inder M Singh
International Archives of Allergy and Applied Immunology
A G Palma-CarlosJ R de Sousa
© 2022 Meta ULC. All rights reserved